Daljeet Kohli has described the USP of his Model Portfolio as “Stock selection criteria here will be strong fundamentals coupled with near term triggers”. One can see this coming true because the “balanced” Portfolio has clocked a return of 29.9% (absolute) in the period from 19.08.2014 to 09.02.2016. In the same period, the Benchmark Index (BSE 500) has lost 3.6. So, the out-perdformance relative to the benchmark is a whopping 33.5%.
|Stock Name||Amt invested||Qty Bought Target Price||MTM Gain/loss|
|Torrent Pharmaceuticals Ltd||100,000||61||1673||(18,915)|
|Camlin Fine Sciences Ltd||100,000||995||177||‐|
|Tata Motors Ltd||100,000||303||496||(5,864)|
|Reliance Industries Ltd||100,000||99||1300||(5,198)|
|Lic Housing Finance Ltd||100,000||515||550||(361)|
|Aurobindo Pharma Ltd*||100,000||181||894||34,425|
|Hero Motocorp Ltd||100,000||39||2715||1,909|
|Karur Vysya Bank Ltd||100,000||195||520||(12,661)|
* 1:1 Bonus Announced
Out of ten stocks in the portfolio, four stocks kept their head above water. Majesco was a stunning winner with a 121% gain. Aurubindo came second with 34% gain. Infosys contributed 25% to the kitty. Hero Motocorp also closed in the green.
The “conservative” portfolio also put up a good show with a return of 12.8% as compared to a loss of 3.6% for the benchmark. SQS BFSI stunned with 96% gains while Shilpa, Cadila, Capital First and Divis contributed with handsome double-digit gains.
However, the “aggressive” portfolio dampened spirits by losing 12.2%. The rogues’ gallery in this portfolio is made up of ICICI Bank, Glenmark, Exide, Federal Bank etc.
For the future, Daljeet has declared no-confidence in HIL. The reason for its fall from grace is its disappointing Q3FY16 results. Its’ outlook for the future also appears to be bleak owing to high raw material costs and slump in demand for asbestos’ products.
HIL’s place has been allotted to Camlin Fine Sciences. Daljeet claims that Camlin has an “Inorganic Action Created Significant Moat” due to the numerous acquisitions of the past. Daljeet is also gung-ho about the Dahej capacity being margin accretive. He has predicted a target price of Rs. 177 for the stock which is a whopping 77% from the CMP of about Rs. 100.